| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | non-membrane spanning protein tyrosine kinase activity | 2.87e-05 | 46 | 26 | 3 | GO:0004715 | |
| GeneOntologyMolecularFunction | histone H3K4 trimethyltransferase activity | 7.29e-05 | 10 | 26 | 2 | GO:0140999 | |
| GeneOntologyMolecularFunction | histone modifying activity | 2.07e-04 | 229 | 26 | 4 | GO:0140993 | |
| GeneOntologyMolecularFunction | transcription corepressor activity | 2.07e-04 | 229 | 26 | 4 | GO:0003714 | |
| GeneOntologyMolecularFunction | histone H3K4 methyltransferase activity | 3.05e-04 | 20 | 26 | 2 | GO:0042800 | |
| GeneOntologyMolecularFunction | transcription coregulator activity | 6.99e-04 | 562 | 26 | 5 | GO:0003712 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase activity | 8.63e-04 | 145 | 26 | 3 | GO:0004713 | |
| GeneOntologyMolecularFunction | histone H3 methyltransferase activity | 1.49e-03 | 44 | 26 | 2 | GO:0140938 | |
| GeneOntologyMolecularFunction | histone acetyltransferase activity | 2.00e-03 | 51 | 26 | 2 | GO:0004402 | |
| GeneOntologyMolecularFunction | peptide-lysine-N-acetyltransferase activity | 2.32e-03 | 55 | 26 | 2 | GO:0061733 | |
| GeneOntologyMolecularFunction | peptide N-acetyltransferase activity | 2.75e-03 | 60 | 26 | 2 | GO:0034212 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | 3.20e-03 | 1160 | 26 | 6 | GO:0030674 | |
| GeneOntologyMolecularFunction | protein-lysine N-methyltransferase activity | 3.52e-03 | 68 | 26 | 2 | GO:0016279 | |
| GeneOntologyMolecularFunction | lysine N-methyltransferase activity | 3.63e-03 | 69 | 26 | 2 | GO:0016278 | |
| GeneOntologyMolecularFunction | histone methyltransferase activity | 3.83e-03 | 71 | 26 | 2 | GO:0042054 | |
| GeneOntologyCellularComponent | asymmetric, glutamatergic, excitatory synapse | 4.04e-04 | 24 | 26 | 2 | GO:0098985 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 2.20e-03 | 56 | 26 | 2 | GO:0099091 | |
| GeneOntologyCellularComponent | cell division site | 4.43e-03 | 80 | 26 | 2 | GO:0032153 | |
| GeneOntologyCellularComponent | actin-based cell projection | 4.82e-03 | 278 | 26 | 3 | GO:0098858 | |
| GeneOntologyCellularComponent | actin cytoskeleton | 5.27e-03 | 576 | 26 | 4 | GO:0015629 | |
| Domain | AHD | 5.59e-06 | 3 | 26 | 2 | IPR012966 | |
| Domain | Anillin | 5.59e-06 | 3 | 26 | 2 | PF08174 | |
| Domain | Chromo | 6.10e-06 | 26 | 26 | 3 | PF00385 | |
| Domain | CHROMO_2 | 7.67e-06 | 28 | 26 | 3 | PS50013 | |
| Domain | CHROMO_1 | 7.67e-06 | 28 | 26 | 3 | PS00598 | |
| Domain | Chromodomain-like | 1.16e-05 | 32 | 26 | 3 | IPR016197 | |
| Domain | CHROMO | 1.27e-05 | 33 | 26 | 3 | SM00298 | |
| Domain | Chromo/shadow_dom | 1.27e-05 | 33 | 26 | 3 | IPR000953 | |
| Domain | Hr1 | 3.90e-05 | 7 | 26 | 2 | SM00742 | |
| Domain | Chromo_dom_subgr | 8.33e-05 | 10 | 26 | 2 | IPR017984 | |
| Domain | TyrKc | 2.43e-04 | 88 | 26 | 3 | SM00219 | |
| Domain | Tyr_kinase_cat_dom | 2.43e-04 | 88 | 26 | 3 | IPR020635 | |
| Domain | Crotonase_core_superfam | 2.50e-04 | 17 | 26 | 2 | IPR001753 | |
| Domain | ECH_1 | 2.50e-04 | 17 | 26 | 2 | PF00378 | |
| Domain | PROTEIN_KINASE_TYR | 3.24e-04 | 97 | 26 | 3 | PS00109 | |
| Domain | Tyr_kinase_AS | 3.24e-04 | 97 | 26 | 3 | IPR008266 | |
| Domain | SH2 | 4.68e-04 | 110 | 26 | 3 | SM00252 | |
| Domain | SH2 | 4.81e-04 | 111 | 26 | 3 | PS50001 | |
| Domain | SH2 | 4.94e-04 | 112 | 26 | 3 | IPR000980 | |
| Domain | - | 4.94e-04 | 112 | 26 | 3 | 3.30.505.10 | |
| Domain | HR1_rho-bd | 5.48e-04 | 25 | 26 | 2 | IPR011072 | |
| Domain | Pkinase_Tyr | 7.45e-04 | 129 | 26 | 3 | PF07714 | |
| Domain | Ser-Thr/Tyr_kinase_cat_dom | 9.06e-04 | 138 | 26 | 3 | IPR001245 | |
| Domain | SET | 1.48e-03 | 41 | 26 | 2 | PF00856 | |
| Domain | SET | 1.86e-03 | 46 | 26 | 2 | SM00317 | |
| Domain | SET_dom | 2.19e-03 | 50 | 26 | 2 | IPR001214 | |
| Domain | SET | 2.19e-03 | 50 | 26 | 2 | PS50280 | |
| Domain | PH_dom-like | 2.68e-03 | 426 | 26 | 4 | IPR011993 | |
| Domain | HMG_box_dom | 3.67e-03 | 65 | 26 | 2 | IPR009071 | |
| Domain | PH | 3.84e-03 | 229 | 26 | 3 | PF00169 | |
| Domain | PHD | 4.86e-03 | 75 | 26 | 2 | PF00628 | |
| Domain | Znf_PHD-finger | 5.38e-03 | 79 | 26 | 2 | IPR019787 | |
| Domain | PH | 6.58e-03 | 278 | 26 | 3 | SM00233 | |
| Domain | PH_DOMAIN | 6.65e-03 | 279 | 26 | 3 | PS50003 | |
| Domain | PH_domain | 6.72e-03 | 280 | 26 | 3 | IPR001849 | |
| Domain | PHD | 6.77e-03 | 89 | 26 | 2 | SM00249 | |
| Domain | Znf_PHD | 7.07e-03 | 91 | 26 | 2 | IPR001965 | |
| Domain | ZF_PHD_2 | 7.68e-03 | 95 | 26 | 2 | PS50016 | |
| Domain | ZF_PHD_1 | 7.84e-03 | 96 | 26 | 2 | PS01359 | |
| Domain | SH2 | 8.65e-03 | 101 | 26 | 2 | PF00017 | |
| Pathway | WP_IL11_SIGNALING | 2.65e-05 | 44 | 19 | 3 | M39716 | |
| Pathway | PID_PTP1B_PATHWAY | 4.40e-05 | 52 | 19 | 3 | M50 | |
| Pathway | PID_FAK_PATHWAY | 6.43e-05 | 59 | 19 | 3 | M281 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 9.00e-05 | 66 | 19 | 3 | MM15925 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 1.13e-04 | 12 | 19 | 2 | MM14835 | |
| Pathway | REACTOME_PECAM1_INTERACTIONS | 1.13e-04 | 12 | 19 | 2 | M11773 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 1.33e-04 | 13 | 19 | 2 | MM14565 | |
| Pathway | REACTOME_REGULATION_OF_KIT_SIGNALING | 2.04e-04 | 16 | 19 | 2 | M537 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 2.60e-04 | 18 | 19 | 2 | MM15023 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 2.90e-04 | 19 | 19 | 2 | MM15512 | |
| Pathway | PID_CXCR4_PATHWAY | 3.09e-04 | 100 | 19 | 3 | M124 | |
| Pathway | REACTOME_SIGNALING_BY_KIT_IN_DISEASE | 3.22e-04 | 20 | 19 | 2 | M39002 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.56e-04 | 21 | 19 | 2 | M5876 | |
| Pathway | REACTOME_CTLA4_INHIBITORY_SIGNALING | 3.56e-04 | 21 | 19 | 2 | MM14996 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 3.57e-04 | 261 | 19 | 4 | MM15676 | |
| Pathway | WP_NRF2ARE_REGULATION | 4.28e-04 | 23 | 19 | 2 | M39761 | |
| Pathway | PID_PRL_SIGNALING_EVENTS_PATHWAY | 4.28e-04 | 23 | 19 | 2 | M11 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_RHOGAP_RHOA_SIGNALING_PATHWAY | 4.28e-04 | 23 | 19 | 2 | M47537 | |
| Pathway | WP_GASTRIN_SIGNALING | 4.66e-04 | 115 | 19 | 3 | M39866 | |
| Pathway | REACTOME_RUNX2_REGULATES_OSTEOBLAST_DIFFERENTIATION | 4.67e-04 | 24 | 19 | 2 | M27803 | |
| Pathway | PID_INTEGRIN_A9B1_PATHWAY | 5.07e-04 | 25 | 19 | 2 | M118 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_CDC42_SIGNALING_PATHWAY | 5.49e-04 | 26 | 19 | 2 | M47719 | |
| Pathway | PID_GLYPICAN_1PATHWAY | 5.92e-04 | 27 | 19 | 2 | M33 | |
| Pathway | WP_NANOPARTICLEMEDIATED_ACTIVATION_OF_RECEPTOR_SIGNALING | 6.37e-04 | 28 | 19 | 2 | M39572 | |
| Pathway | REACTOME_EPHA_MEDIATED_GROWTH_CONE_COLLAPSE | 6.84e-04 | 29 | 19 | 2 | M27309 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 7.32e-04 | 30 | 19 | 2 | M27772 | |
| Pathway | PID_EPHRINB_REV_PATHWAY | 7.32e-04 | 30 | 19 | 2 | M257 | |
| Pathway | PID_P38_ALPHA_BETA_PATHWAY | 7.32e-04 | 30 | 19 | 2 | M76 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ITGA_B_FAK_RAC_SIGNALING_PATHWAY | 7.32e-04 | 30 | 19 | 2 | M47718 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 7.32e-04 | 30 | 19 | 2 | MM15517 | |
| Pathway | REACTOME_SIGNALING_BY_CSF1_M_CSF_IN_MYELOID_CELLS | 7.82e-04 | 31 | 19 | 2 | M46423 | |
| Pathway | REACTOME_RUNX2_REGULATES_BONE_DEVELOPMENT | 7.82e-04 | 31 | 19 | 2 | M27805 | |
| Pathway | PID_NETRIN_PATHWAY | 8.33e-04 | 32 | 19 | 2 | M108 | |
| Pathway | PID_ALPHA_SYNUCLEIN_PATHWAY | 8.33e-04 | 32 | 19 | 2 | M275 | |
| Pathway | PID_SYNDECAN_2_PATHWAY | 8.86e-04 | 33 | 19 | 2 | M240 | |
| Pathway | PID_INTEGRIN_A4B1_PATHWAY | 8.86e-04 | 33 | 19 | 2 | M277 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 8.86e-04 | 33 | 19 | 2 | M11725 | |
| Pathway | PID_EPHA_FWDPATHWAY | 9.41e-04 | 34 | 19 | 2 | M177 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 9.41e-04 | 34 | 19 | 2 | MM15025 | |
| Pathway | REACTOME_CD28_CO_STIMULATION | 9.41e-04 | 34 | 19 | 2 | MM14992 | |
| Pathway | WP_HEPATOCYTE_GROWTH_FACTOR_RECEPTOR_SIGNALING | 9.41e-04 | 34 | 19 | 2 | M39383 | |
| Pathway | REACTOME_POTENTIAL_THERAPEUTICS_FOR_SARS | 1.09e-03 | 154 | 19 | 3 | M39007 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.11e-03 | 37 | 19 | 2 | MM15022 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.11e-03 | 37 | 19 | 2 | MM14564 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.17e-03 | 158 | 19 | 3 | MM14812 | |
| Pathway | REACTOME_RET_SIGNALING | 1.18e-03 | 38 | 19 | 2 | MM15493 | |
| Pathway | PID_RET_PATHWAY | 1.24e-03 | 39 | 19 | 2 | M82 | |
| Pathway | REACTOME_RET_SIGNALING | 1.30e-03 | 40 | 19 | 2 | M27746 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 1.37e-03 | 41 | 19 | 2 | M27778 | |
| Pathway | PID_AMB2_NEUTROPHILS_PATHWAY | 1.37e-03 | 41 | 19 | 2 | M159 | |
| Pathway | REACTOME_EPHB_MEDIATED_FORWARD_SIGNALING | 1.43e-03 | 42 | 19 | 2 | M27308 | |
| Pathway | PID_UPA_UPAR_PATHWAY | 1.43e-03 | 42 | 19 | 2 | M174 | |
| Pathway | PID_TCPTP_PATHWAY | 1.43e-03 | 42 | 19 | 2 | M91 | |
| Pathway | REACTOME_SIGNALING_BY_SCF_KIT | 1.50e-03 | 43 | 19 | 2 | M508 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 1.57e-03 | 44 | 19 | 2 | MM14520 | |
| Pathway | REACTOME_GPER1_SIGNALING | 1.65e-03 | 45 | 19 | 2 | M45008 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.79e-03 | 47 | 19 | 2 | M39829 | |
| Pathway | WP_THYMIC_STROMAL_LYMPHOPOIETIN_TSLP_SIGNALING | 1.79e-03 | 47 | 19 | 2 | M39380 | |
| Pathway | PID_PI3KCI_PATHWAY | 1.87e-03 | 48 | 19 | 2 | M141 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 1.87e-03 | 48 | 19 | 2 | MM17214 | |
| Pathway | WP_TROP2_REGULATORY_SIGNALING | 1.95e-03 | 49 | 19 | 2 | M46458 | |
| Pathway | REACTOME_SIGNALING_BY_ERBB2 | 2.03e-03 | 50 | 19 | 2 | M553 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 2.07e-03 | 418 | 19 | 4 | MM15587 | |
| Pathway | REACTOME_EPH_EPHRIN_MEDIATED_REPULSION_OF_CELLS | 2.11e-03 | 51 | 19 | 2 | M27311 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 2.11e-03 | 194 | 19 | 3 | M16312 | |
| Pathway | PID_TXA2PATHWAY | 2.54e-03 | 56 | 19 | 2 | M99 | |
| Pathway | REACTOME_SIGNALING_BY_INTERLEUKINS | 3.25e-03 | 473 | 19 | 4 | M874 | |
| Pathway | REACTOME_CYTOKINE_SIGNALING_IN_IMMUNE_SYSTEM | 3.27e-03 | 789 | 19 | 5 | M1060 | |
| Pathway | WP_HISTONE_MODIFICATIONS | 3.40e-03 | 65 | 19 | 2 | M39374 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 3.40e-03 | 65 | 19 | 2 | MM14911 | |
| Pathway | WP_ONCOSTATIN_M_SIGNALING | 3.40e-03 | 65 | 19 | 2 | M39562 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 3.51e-03 | 66 | 19 | 2 | MM14990 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 3.61e-03 | 67 | 19 | 2 | MM15345 | |
| Pathway | WP_RAC1PAK1P38MMP2_PATHWAY | 3.72e-03 | 68 | 19 | 2 | M39456 | |
| Pathway | REACTOME_L1CAM_INTERACTIONS | 3.72e-03 | 68 | 19 | 2 | MM14968 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 3.83e-03 | 69 | 19 | 2 | M27108 | |
| Pathway | REACTOME_PKMTS_METHYLATE_HISTONE_LYSINES | 3.94e-03 | 70 | 19 | 2 | M27231 | |
| Pathway | PID_CDC42_PATHWAY | 3.94e-03 | 70 | 19 | 2 | M81 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 4.02e-03 | 502 | 19 | 4 | MM14537 | |
| Pathway | WP_KIT_RECEPTOR_SIGNALING_PATHWAY | 4.05e-03 | 71 | 19 | 2 | MM15947 | |
| Pathway | WP_AXON_GUIDANCE | 4.16e-03 | 72 | 19 | 2 | M48335 | |
| Pathway | KEGG_ADHERENS_JUNCTION | 4.27e-03 | 73 | 19 | 2 | M638 | |
| Pathway | REACTOME_COSTIMULATION_BY_THE_CD28_FAMILY | 4.39e-03 | 74 | 19 | 2 | M17386 | |
| Pathway | REACTOME_SIGNALING_BY_NTRKS | 4.50e-03 | 75 | 19 | 2 | MM14652 | |
| Pathway | WP_PROLACTIN_SIGNALING | 4.62e-03 | 76 | 19 | 2 | M39601 | |
| Pathway | WP_REGULATORY_CIRCUITS_OF_STAT3_SIGNALING | 4.86e-03 | 78 | 19 | 2 | M39824 | |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | 4.95e-03 | 532 | 19 | 4 | M27870 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 4.98e-03 | 79 | 19 | 2 | M27643 | |
| Pathway | REACTOME_CHROMATIN_MODIFYING_ENZYMES | 5.48e-03 | 272 | 19 | 3 | M29619 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 6.51e-03 | 575 | 19 | 4 | M29853 | |
| Pathway | REACTOME_EPH_EPHRIN_SIGNALING | 6.70e-03 | 92 | 19 | 2 | M27201 | |
| Pubmed | Mammalian chromodomain proteins: their role in genome organisation and expression. | 2.07e-08 | 8 | 26 | 3 | 10655032 | |
| Pubmed | Integrin signalling regulates YAP and TAZ to control skin homeostasis. | 1.68e-07 | 15 | 26 | 3 | 26989177 | |
| Pubmed | Elevated c-Src and c-Yes expression in malignant skin cancers. | 5.37e-07 | 2 | 26 | 2 | 20796316 | |
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 21901128 | ||
| Pubmed | 5.37e-07 | 2 | 26 | 2 | 7507074 | ||
| Pubmed | The SRC family protein tyrosine kinase p62yes controls polymeric IgA transcytosis in vivo. | 5.37e-07 | 2 | 26 | 2 | 10549294 | |
| Pubmed | Specific oncogenic activity of the Src-family tyrosine kinase c-Yes in colon carcinoma cells. | 5.37e-07 | 2 | 26 | 2 | 21390316 | |
| Pubmed | Src family kinases are required for integrin but not PDGFR signal transduction. | 1.61e-06 | 3 | 26 | 2 | 10228160 | |
| Pubmed | Localized activation of Src-family protein kinases in the mouse egg. | 1.61e-06 | 3 | 26 | 2 | 17449027 | |
| Pubmed | Combined deficiencies of Src, Fyn, and Yes tyrosine kinases in mutant mice. | 1.61e-06 | 3 | 26 | 2 | 7958873 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 23497302 | ||
| Pubmed | Src, Fyn and Yes play differential roles in VEGF-mediated endothelial cell events. | 1.61e-06 | 3 | 26 | 2 | 16400523 | |
| Pubmed | Requirement of SRC-family tyrosine kinases in fat accumulation. | 1.61e-06 | 3 | 26 | 2 | 16262245 | |
| Pubmed | Cellular tension encodes local Src-dependent differential β1 and β3 integrin mobility. | 1.61e-06 | 3 | 26 | 2 | 30462575 | |
| Pubmed | Anthrax toxin triggers the activation of src-like kinases to mediate its own uptake. | 1.61e-06 | 3 | 26 | 2 | 20080640 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 22247553 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 20176789 | ||
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 31654241 | ||
| Pubmed | Integrin-mediated host cell invasion by type 1-piliated uropathogenic Escherichia coli. | 1.61e-06 | 3 | 26 | 2 | 17630833 | |
| Pubmed | Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. | 1.61e-06 | 3 | 26 | 2 | 10635317 | |
| Pubmed | 1.61e-06 | 3 | 26 | 2 | 18322799 | ||
| Pubmed | CD44 engagement promotes matrix-derived survival through the CD44-SRC-integrin axis in lipid rafts. | 1.61e-06 | 3 | 26 | 2 | 18644869 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 30088837 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 21045155 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 7681396 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11039464 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11245687 | ||
| Pubmed | Autophosphorylation activity and association with Src family kinase of Sky receptor tyrosine kinase. | 3.22e-06 | 4 | 26 | 2 | 7537495 | |
| Pubmed | Endocytosis of collagen by hepatic stellate cells regulates extracellular matrix dynamics. | 3.22e-06 | 4 | 26 | 2 | 25080486 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 19258394 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 19470583 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 16585062 | ||
| Pubmed | Src promotes GTPase activity of Ras via tyrosine 32 phosphorylation. | 3.22e-06 | 4 | 26 | 2 | 25157176 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 11127814 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 7521304 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 34944014 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 9806824 | ||
| Pubmed | State and role of SRC family kinases in replication of herpes simplex virus 1. | 3.22e-06 | 4 | 26 | 2 | 16537602 | |
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 16882656 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 14559149 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 12149400 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 19887442 | ||
| Pubmed | 3.22e-06 | 4 | 26 | 2 | 14691141 | ||
| Pubmed | Palatal adhesion is dependent on Src family kinases and p38MAPK. | 5.37e-06 | 5 | 26 | 2 | 25354453 | |
| Pubmed | Clustering-induced tyrosine phosphorylation of nephrin by Src family kinases. | 5.37e-06 | 5 | 26 | 2 | 12846735 | |
| Pubmed | p27 phosphorylation by Src regulates inhibition of cyclin E-Cdk2. | 5.37e-06 | 5 | 26 | 2 | 17254967 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 18483622 | ||
| Pubmed | Angiopoietin-1 prevents VEGF-induced endothelial permeability by sequestering Src through mDia. | 5.37e-06 | 5 | 26 | 2 | 18194650 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 15522237 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 19147496 | ||
| Pubmed | Focal adhesion kinase is required for β-catenin-induced mobilization of epidermal stem cells. | 5.37e-06 | 5 | 26 | 2 | 22971575 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 25477471 | ||
| Pubmed | Retroposition of autosomal mRNA yielded testis-specific gene family on human Y chromosome. | 5.37e-06 | 5 | 26 | 2 | 10192397 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 18255094 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 17623777 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 12509223 | ||
| Pubmed | A gp130-Src-YAP module links inflammation to epithelial regeneration. | 5.37e-06 | 5 | 26 | 2 | 25731159 | |
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 11448999 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 10844001 | ||
| Pubmed | 5.37e-06 | 5 | 26 | 2 | 21233420 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 19420001 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 20606012 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 15557335 | ||
| Pubmed | Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis. | 8.05e-06 | 6 | 26 | 2 | 10861086 | |
| Pubmed | Slit2/Robo4 signaling modulates HIV-1 gp120-induced lymphatic hyperpermeability. | 8.05e-06 | 6 | 26 | 2 | 22241990 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 12923167 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 9799234 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 18328427 | ||
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 16723512 | ||
| Pubmed | Specific expression of a tyrosine kinase gene, blk, in B lymphoid cells. | 8.05e-06 | 6 | 26 | 2 | 2404338 | |
| Pubmed | 8.05e-06 | 6 | 26 | 2 | 1381360 | ||
| Pubmed | The SRC-associated protein CUB Domain-Containing Protein-1 regulates adhesion and motility. | 8.05e-06 | 6 | 26 | 2 | 21725358 | |
| Pubmed | Fyn tyrosine kinase is a critical regulator of disabled-1 during brain development. | 1.13e-05 | 7 | 26 | 2 | 12526739 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 9632142 | ||
| Pubmed | Direct reprogramming of stem cell properties in colon cancer cells by CD44. | 1.13e-05 | 7 | 26 | 2 | 21701559 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 12538589 | ||
| Pubmed | CMS: an adapter molecule involved in cytoskeletal rearrangements. | 1.13e-05 | 7 | 26 | 2 | 10339567 | |
| Pubmed | Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin. | 1.13e-05 | 7 | 26 | 2 | 12558988 | |
| Pubmed | The kinase-deficient Src acts as a suppressor of the Abl kinase for Cbl phosphorylation. | 1.13e-05 | 7 | 26 | 2 | 10829062 | |
| Pubmed | QM, a putative tumor suppressor, regulates proto-oncogene c-yes. | 1.13e-05 | 7 | 26 | 2 | 12138090 | |
| Pubmed | Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis. | 1.13e-05 | 7 | 26 | 2 | 19267251 | |
| Pubmed | 1.13e-05 | 7 | 26 | 2 | 10858437 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 22402981 | ||
| Pubmed | The Cdc42-associated kinase ACK1 is not autoinhibited but requires Src for activation. | 1.50e-05 | 8 | 26 | 2 | 21309750 | |
| Pubmed | Phosphorylation of SOCS1 Inhibits the SOCS1-p53 Tumor Suppressor Axis. | 1.50e-05 | 8 | 26 | 2 | 31101761 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 12640114 | ||
| Pubmed | The Lyn kinase C-lobe mediates Golgi export of Lyn through conformation-dependent ACSL3 association. | 1.50e-05 | 8 | 26 | 2 | 20605918 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 15190072 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 8918464 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 21829547 | ||
| Pubmed | Differential kinase requirements in human and mouse Fc-gamma receptor phagocytosis and endocytosis. | 1.50e-05 | 8 | 26 | 2 | 16921024 | |
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 24036928 | ||
| Pubmed | 1.50e-05 | 8 | 26 | 2 | 7499252 | ||
| Pubmed | Previously uncharacterized histone acetyltransferases implicated in mammalian spermatogenesis. | 1.50e-05 | 8 | 26 | 2 | 12072557 | |
| Pubmed | Gab2 is involved in differential phosphoinositide 3-kinase signaling by two splice forms of c-Kit. | 1.93e-05 | 9 | 26 | 2 | 18697750 | |
| Pubmed | Activation of a Dab1/CrkL/C3G/Rap1 pathway in Reelin-stimulated neurons. | 2.41e-05 | 10 | 26 | 2 | 15062102 | |
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 18155796 | ||
| Pubmed | 2.41e-05 | 10 | 26 | 2 | 16687575 | ||
| Pubmed | SRC family kinases are required for limb trajectory selection by spinal motor axons. | 2.94e-05 | 11 | 26 | 2 | 19403835 | |
| Pubmed | 2.94e-05 | 11 | 26 | 2 | 11312300 | ||
| Interaction | CD46 interactions | 1.27e-05 | 37 | 25 | 3 | int:CD46 | |
| Interaction | CD36 interactions | 1.50e-05 | 39 | 25 | 3 | int:CD36 | |
| Interaction | KMT2A interactions | 3.66e-05 | 314 | 25 | 5 | int:KMT2A | |
| Interaction | EDNRA interactions | 3.79e-05 | 53 | 25 | 3 | int:EDNRA | |
| Interaction | H3C14 interactions | 3.85e-05 | 156 | 25 | 4 | int:H3C14 | |
| Interaction | DOK1 interactions | 5.24e-05 | 59 | 25 | 3 | int:DOK1 | |
| Interaction | NMRK2 interactions | 5.29e-05 | 9 | 25 | 2 | int:NMRK2 | |
| Interaction | IGSF9B interactions | 6.61e-05 | 10 | 25 | 2 | int:IGSF9B | |
| Interaction | H4C6 interactions | 8.37e-05 | 69 | 25 | 3 | int:H4C6 | |
| Interaction | PTPRC interactions | 8.37e-05 | 69 | 25 | 3 | int:PTPRC | |
| Interaction | CSF1R interactions | 1.07e-04 | 75 | 25 | 3 | int:CSF1R | |
| Interaction | ACBD7 interactions | 1.33e-04 | 14 | 25 | 2 | int:ACBD7 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q32 | 1.17e-02 | 290 | 26 | 2 | chr1q32 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chrYq11 | 1.34e-02 | 311 | 26 | 2 | chrYq11 | |
| GeneFamily | Zinc fingers C2H2-type|Lysine methyltransferases|PR/SET domain family | 5.75e-04 | 34 | 19 | 2 | 487 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 1.23e-03 | 206 | 19 | 3 | 682 | |
| GeneFamily | PHD finger proteins | 3.97e-03 | 90 | 19 | 2 | 88 | |
| GeneFamily | SH2 domain containing | 4.97e-03 | 101 | 19 | 2 | 741 | |
| ToppCell | droplet-Spleen-nan-24m-Lymphocytic-immature_NKT_cell|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.77e-06 | 184 | 26 | 4 | b998803180322a5ea2b567928dea531c26816c3c | |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 4.94e-06 | 197 | 26 | 4 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| Drug | dinitrophenyl-human serum albumin conjugate | 4.49e-05 | 9 | 26 | 2 | ctd:C058064 | |
| Drug | 27-hydroxycholesterol | 4.78e-05 | 62 | 26 | 3 | ctd:C076996 | |
| Drug | Dasatinib | 5.61e-05 | 10 | 26 | 2 | DB01254 | |
| Drug | ponatinib | 6.31e-05 | 68 | 26 | 3 | ctd:C545373 | |
| Drug | Azacyclonol [115-46-8]; Down 200; 15uM; PC3; HG-U133A | 6.34e-05 | 192 | 26 | 4 | 1937_DN | |
| Drug | AC1L1J0H | 7.00e-05 | 197 | 26 | 4 | CID000004813 | |
| Drug | Diphenhydramine hydrochloride [147-24-0]; Down 200; 13.8uM; PC3; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 1830_DN | |
| Drug | Canavanine sulfate monohydrate (L,+) [206996-57-8]; Up 200; 13.6uM; MCF7; HT_HG-U133A | 7.14e-05 | 198 | 26 | 4 | 4782_UP | |
| Drug | Flumethasone [2135-17-3]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 7.28e-05 | 199 | 26 | 4 | 3410_DN | |
| Disease | interferon alpha/beta receptor 1 measurement | 2.27e-05 | 9 | 24 | 2 | EFO_0021850 | |
| Disease | Spermatogenic Failure, Nonobstructive, Y-Linked | 7.56e-05 | 16 | 24 | 2 | C1839071 | |
| Disease | SPERMATOGENIC FAILURE, Y-LINKED, 2 | 7.56e-05 | 16 | 24 | 2 | 415000 | |
| Disease | Spermatogenic failure, Y-linked, 2 | 7.56e-05 | 16 | 24 | 2 | cv:C1839071 | |
| Disease | colon adenocarcinoma (is_implicated_in) | 2.04e-04 | 26 | 24 | 2 | DOID:234 (is_implicated_in) | |
| Disease | colorectal cancer (implicated_via_orthology) | 2.72e-04 | 30 | 24 | 2 | DOID:9256 (implicated_via_orthology) | |
| Disease | intestinal cancer (implicated_via_orthology) | 3.10e-04 | 32 | 24 | 2 | DOID:10155 (implicated_via_orthology) | |
| Disease | kidney disease (implicated_via_orthology) | 5.10e-04 | 41 | 24 | 2 | DOID:557 (implicated_via_orthology) | |
| Disease | nasopharynx carcinoma (is_marker_for) | 5.61e-04 | 43 | 24 | 2 | DOID:9261 (is_marker_for) | |
| Disease | lung adenocarcinoma (is_implicated_in) | 7.28e-04 | 49 | 24 | 2 | DOID:3910 (is_implicated_in) | |
| Disease | carcinoma (implicated_via_orthology) | 1.24e-03 | 64 | 24 | 2 | DOID:305 (implicated_via_orthology) | |
| Disease | cancer (implicated_via_orthology) | 1.30e-03 | 268 | 24 | 3 | DOID:162 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| WPACAQKIMDHVEES | 191 | Q6PJG6 | |
| DTWEPEQHLMNCEKC | 36 | Q9Y6F8 | |
| DTWEPEQHLMNCEKC | 36 | Q9Y6F7 | |
| MVKGKDEWDIPHICN | 211 | Q96QA5 | |
| MKVITCEIAWHNKEP | 1 | Q13112 | |
| DPVSHCKEKDVDDCW | 686 | P05556 | |
| NMCKRWVHLECDKPT | 486 | Q8NEZ4 | |
| GKCIPEAWKCNNMDE | 176 | Q9Y561 | |
| SEWLKGCDMHVKIDP | 141 | Q96QH8 | |
| MHPEDLGCCLLKEWT | 181 | O60906 | |
| EERWMKEDCTHCICE | 1406 | A1KZ92 | |
| KMGSEDWEKDEPQCC | 11 | Q9NZH6 | |
| SELEAEEWCKHLCME | 96 | Q6PKX4 | |
| CPHCEKEGIQWEAKE | 411 | Q14839 | |
| SQWKHCCEELMKIEI | 396 | Q8IZC4 | |
| WKQCCDEIMKIETPA | 421 | Q9BST9 | |
| PESLHDLMCQCWRKE | 491 | P12931 | |
| CLEQEKEPWNMKRHE | 86 | Q8TF32 | |
| LDKCMQDHDCKDWVH | 626 | Q6SZW1 | |
| LMLAKAKECWEQEHE | 21 | P19237 | |
| HFMELCWDKCVEKPG | 31 | Q9Y5J9 | |
| CIPWEMKIKDIESHF | 231 | Q8TDI7 | |
| VECQKEDWPMHKLEC | 76 | Q9NRG4 | |
| PCEVYHLMKNCWETE | 1141 | P29597 | |
| LHELMNLCWKKDPDE | 501 | P07947 | |
| CEVRERCWKDHCMDK | 366 | Q92802 |